Mechanical ventilation in Guillain-Barré syndrome: Does age influence functional outcome?

European Neurology

Volumn 61, Issue 6, 2009, Pages 358-363

  Köhrmann, Martin ^a,b   Huttner, Hagen B ^a   Nowe, Tim ^a   Schellinger, Peter D ^a   Schwab, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Guillain Barr syndrome; Neurocritical care; Neuromuscular diseases; Ventilation

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BULBAR PARALYSIS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DYSAUTONOMIA; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GROUPS BY AGE; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; INFECTION; INTENSIVE CARE; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLASMAPHERESIS; PRIORITY JOURNAL; TRACHEOSTOMY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INTERVIEWS AS TOPIC; MIDDLE AGED; PLASMA EXCHANGE; RECOVERY OF FUNCTION; REGRESSION ANALYSIS; RESPIRATION, ARTIFICIAL; TRACHEOSTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 64149117008     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210548     Document Type: Article

References (33)

1. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF: Anticipating mechanical ventilation in Guillain-Barrésyndrome. Arch Neurol 2001;58:893-898.
2. Ropper AH: Unusual clinical variants and signs in Guillain- Barrésyndrome. Arch Neurol 1986;43:1150-1152.
3. Winer JB, Hughes RA, Greenwood RJ, Per-kin GD, Healy MJ: Prognosis in Guillain-Barrésyndrome. Lancet 1985;i:1202-1203.
4. Winer JB, Hughes RA, Osmond C: A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988;51:605-612.
5. Lawn ND, Wijdicks EF: Fatal Guillain-Barrésyndrome. Neurolog y 1999;52:635-638.
6. Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF: Long-term outcome in patients with Guillain-Barrésyndrome requiring mechanical ventilation. Neurology 2000;54:2311-2315.
7. Diener HC, Haupt WF, Kloss TM, Rosenow F, Philipp T, Koeppen S, Vietorisz A: A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain- Barrésyndrome. Eur Neurol 2001;46:107-109.
8. De Rooij SE, Abu-Hanna A, Levi M, de Jonge E: Factors that predict outcome of intensive care treatment in very elderly patients: a review. Crit Care 2005;9:R307-R314.
9. Chelluri L, Grenvik A, Silverman M: Intensive care for critically ill elderly: mortality, costs, and quality of life. Review of the literature. Arch Intern Med 1995;155:1013-1022.
10. Kass JE, Castriotta RJ, Malakoff F: Intensive care unit outcome in the very elderly. Crit Care Med 1992;20:1666-1671.
11. Hennessy D, Juzwishin K, Yergens D, Nose-worthy T, Doig C: Outcomes of elderly survivors of intensive care: a review of the literature. Chest 2005;127:1764-1774.
12. Cheng BC, Chang WN, Chang CS, Tsai NW, Chang CJ, Hung PL, Wang KW, Chen JB, Tsai CY, Hsu KT, Chang HW, Lu CH: Predictive factors and long-term outcome of respiratory failure after Guillain-Barrésyndrome. Am J Med Sci 2004;327:336-340.
13. Dhar R, Stitt L, Hahn AF: The morbidity and outcome of patients with Guillain-Barrésyndrome admitted to the intensive care unit. J Neurol Sci 2008;264:121-128.
14. Hughes RA, Cornblath DR: Guillain-Barrésyndrome. Lancet 2005;366:1653-1666.
15. Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Bar-résyndrome. Ann Neurol 1990;27(suppl): S21-S24.
16. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka K V, Swan AV;Plasma Exchange/Sandoglobulin Guillain-BarréSyndrome Trial Group: Electrophysi-ological classification of Guillain-Barrésyndrome: clinical associations and outcome. Ann Neurol 1998;44:780-788.
17. Flachenecker P, Wermuth P, Hartung HP, Reiners K: Quantitative assessment of cardiovascular autonomic function in Guillain-Barrésyndrome. Ann Neurol 1997;42:171-179.
18. Chelluri L, Pinsky MR, Donahoe MP, Gren-vik A: Long-term outcome of critically ill elderly patients requiring intensive care. JAMA 1993;269:3119-3123.
19. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM: Controlled trial prednisolone in acute poly neuropathy. Lancet 1978;2:750-753.
20. Wood KA, Ely EW: What does it mean to be critically ill and elderly? Curr Opin Crit Care 2003;9:316-320.
21. Ng KK, Howard RS, Fish DR, Hirsch NP, Wiles CM, Murray NM, Miller DH: Management and outcome of severe Guillain-Barrésy ndrome. QJM 1995;88:243-250.
22. Lawn ND, Wijdicks EF: Tracheostomy in Guillain-Barrésyndrome. Muscle Nerve 1999;22:1058-1062.
23. Wijdicks EF, Borel CO: Respiratory management in acute neurologic illness. Neurology 1998;50:11-20.
24. Aggarwal AN, Gupta D, Lal V, Behera D, Jindal SK, Prabhakar S: Ventilatory management of respiratory failure in patients with severe Guillain-Barrésyndrome. Neurol India 2003;51:203-205.
25. Plasma Exchange/Sandoglobulin Guillain-BarréSyndrome Trial Group: Randomised trial of plasma exchange, intravenous immu-noglobulin, and combined treatments in Guillain-Barrésyndrome. Lancet 1997;349:225-230.
26. Hughes RA, Raphael JC, Swan AV, Doorn PA: Intravenous immunoglobulin for Guil-lain-Barrésyndrome. Cochrane Database Syst Rev 2004:CD002063.
27. Raphael JC, Chevret S, Hughes RA, Annane D: Plasma exchange for Guillain-Barrésyndrome. Cochrane Database Syst Rev 2002: CD001798.
28. Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Miller RG, Sladky JT, Stevens JC: Practice parameter: immunotherapy for Guillain-Barrésyndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurolog y 2003;61:736-740.
29. Henderson RD, Lawn ND, Fletcher DD, McClelland RL, Wijdicks EF: The morbidity of Gu i l lain-Bar résy ndrome admitted to the in-tensive care unit. Neurology 2003;60:17-21.
30. Campion EW, Mulley AG, Goldstein RL, Barnett GO, Thibault GE: Medical intensive care for the elderly. A study of current use, costs, and outcomes. JAMA 1981;246:2052-2056.
31. Rees JH, Thompson RD, Smeeton NC, Hughes RA: Epidemiological study of Guil-lain-Barrésyndrome in south east England. J Neurol Neurosurg Psychiatr y 1998;64:74-77.
32. Newton-John H: Prevention of pulmonary complications in severe Guillain-Barrésyndrome by early assisted ventilation. Med J Aust 1985;142:444-445.
33. Koeppen S, Kraywinkel K, Wessendorf TE, Ehrenfeld CE, Schurks M, Diener HC, Weimar C: Long-term outcome of Guillain-Bar-résyndrome. Neurocrit Care 2006;5:235-242.